General MedicationsINTRAVENOUSStandard
VORICONAZOLE
VORICONAZOLE
Standard Dose
200MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview VORICONAZOLE is listed in Drugs@FDA under application 218533 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient VORICONAZOLE Form and strength POWDER;INTRAVENOUS - 200MG/VIAL Sponsor ASPIRO Submission history Latest submission status date: 2025-07-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview VORICONAZOLE is listed in Drugs@FDA under application 218533 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient VORICONAZOLE Form and strength POWDER;INTRAVENOUS - 200MG/VIAL Sponsor ASPIRO Submission history Latest submission status date: 2025-07-18 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.